nelfinavir has been researched along with Carcinoma, Renal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abt, D; Bader, J; Besse, A; Besse, L; Driessen, C; Engeler, DS; Kraus, M; Schmid, HP; Sedlarikova, L; Silzle, T; Slaby, O; Vodinska, M | 1 |
| Asano, T; Isono, M; Okubo, K; Sato, A | 1 |
2 other study(ies) available for nelfinavir and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; HIV Protease Inhibitors; Humans; Kidney Neoplasms; Lopinavir; Nelfinavir; Proteasome Inhibitors | 2018 |
Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum Stress; Female; HIV Protease Inhibitors; Humans; Hydroxamic Acids; Indoles; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nelfinavir; Panobinostat; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |